Even geduld alstublieft, we laden de grafiekgegevens
AstraZeneca PLC-community
About AstraZeneca PLC
What is AstraZeneca PLC?
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is € 164,25, with a 24-hour trading volume of € 70,86M. The asset's market cap is € 254,43B, after moving -3.91% in the last day.
Tokenized AstraZeneca PLC is trading at € 83,69, with a tokenized market cap of € 47,38M and a 24-hour trading volume of € 711,53K. The tokenized asset has moved -4.24% in the past 24 hours.